Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
3350000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 19th Stock Acquisition Rights issued through third-party allotment (with Exercise Price Adjustment Clause)
発行・処分する株式数
3,350,000 new shares (number of shares delivered between 1 July and 6 July 2026)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Existing Shares and Increase
+3.40%Rate of increase
97,334,098 shares100,684,098Shares
3,350,000 shares delivered from the beginning of the month / 97,334,098 shares issued and outstanding at the end of the previous month, approximately 3.4%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥31.0 on 1 July and ¥33.0 on 3 July and 6 July. Details of the adjustment clause and the lower limit of the adjustment are Not disclosed
Number of Stock Acquisition Rights
Total issued: 240,000 rights; exercised from the beginning of the month: 33,500 rights; unexercised as of the current date: 196,500 rights
Most recent equity financing
The 19th Stock Acquisition Rights issued on 12 June 2026, with EVO FUND as the allottee (with Exercise Price Adjustment Clause). Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 19th Stock Acquisition Rights issued through third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | 3,350,000 new shares (number of shares delivered between 1 July and 6 July 2026) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 3,350,000 shares delivered from the beginning of the month / 97,334,098 shares issued and outstanding at the end of the previous month, approximately 3.4% |
| Total number of issued shares | 97,334,098 shares (as of the end of the month preceding the month under review) → 100,684,098 shares (the number of shares issued and outstanding at the end of the previous month plus the number of new shares delivered from the beginning of the month)（Approximately 3.4%） |
| Exercise price | ¥31.0 on 1 July and ¥33.0 on 3 July and 6 July. Details of the adjustment clause and the lower limit of the adjustment are Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 240,000 rights; exercised from the beginning of the month: 33,500 rights; unexercised as of the current date: 196,500 rights |
| Most recent equity financing | The 19th Stock Acquisition Rights issued on 12 June 2026, with EVO FUND as the allottee (with Exercise Price Adjustment Clause). Amount: Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company reported the large-scale exercise but did not state the reason for the exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.